Objective-Biologics are highly effective in ankylosing spondylitis (AS). In this selfcontrolled study, we assessed the additive value of complex physiotherapy in decreasing chest -2 -pain and tenderness and improving respiratory function in AS patients treated with tumor necrosis factor α (TNF-α) inhibitors.
Introduction
Ankylosing spondylitis (AS) is a chronic inflammatory disease involving entheses and joints around the spine. The most widespread involvement of the respiratory system occurs when this pathological process gives rise to chest pain with kyphosis and decreased chest expansion.
During healing of the inflammatory process, calcification occurs, leading to rigidity with a consequent decrease of chest expansion-which is exacerbated by the kyphotic spinal structure and intercostal muscles inefficiency-and changed respiratory function [1, 2, 3, 4] . __Patients with chest pain and without accompanying respiratory symptoms (dyspnea or cough), suffer from primary musculoskeletal involvement. With subsequent involvement of the thoracic spine and occurrence of enthesopathy at the costosternal and manubriosternal joints, patients may experience chest pain when coughing or sneezing [5, 6, 7] . __Since mostly the structural changes of the chest wall trigger chest pain, the cause can be obviously detected by palpation, localized swelling, and tender points. Some of the characteristic trigger points include the upper trapezius, sternocostal and costochondral junction, manubriosternal junction, the vertebral spinous processes, and the xiphoid process [8] . For AS patients, active disease means pain, mobility restriction, muscle tension, inability to stay supine, restriction in chest mobility, dyspnea, disturbed sleep, and difficulty to breathe [6, 9] . __Progressive ankylosis of the thoracic spine in AS will eventually lead to restrictive pulmonary function impairment, characterized by reduced vital capacity (VC), increased ratio of forced 1-s expiratory volume (FEV1) and forced vital capacity (FVC) . Respiratory function in AS shows a typical restrictive pattern, which is characterized by decrease of FVC <80% and FEV1 with normal FEV1/FVC ratio [1, 7, 10] . __Both pharmacological treatment with primarily tumor necrosis factor-α (TNF-α) inhibitors and complex physical exercise are effective and important [11, 12, 13] . Anti-TNF agents are particularly effective during the early, inflammatory stages of the disease [4, 11] . Biologics are able to decrease inflammatory pain and muscle stiffness, and improve functional capacity, mobility and quality of life [11] . Physical therapy may have additive value by maintaining or even improving mobility, fitness, and general health. It also plays an important role in the prevention and management of the deformities related to AS [13, 14] .
__In our previous study we analyzed 75 AS patients from the point of view of gender differences and they did not show obvious variances [15] . Therefore in the current study (I), we retrospectively examined the same patients being on the basis therapy whether there are differences of physical and certain functional parameters between patient with or without biological therapy, and (II) prospectively, in a small, volunteer group of AS patients treated with biological we assessed the effects of a targeted physical therapy program on chest pain, tenderness, mobility, and respiratory function. It was hypothesized that AS patients receiving biological therapy may have further benefit from a targeted physical therapy program. All patients had definite AS according to the modified New York criteria [16] . Informed consent was obtained from all participants. Anthropometrical data, time since diagnosis and patient assessment of disease activity, functional capacity, BASDAI (Bath Ankylosing Spondylitis Disease Activity Index) and BASFI (Bath Ankylosing Spondylitis Functional Index), pain intensity on a VAS (visual analog scale), drugs history, sacroiliitis stage assessed by X-ray, and levels of physical activity were recorded. Functional and physical tests were performed by the same physician as described below. None of the patients had a history of cardiopulmonary diseases. Study II (prospective, self-coontrolled analysis)-Of the 55 AS patients with biological therapy described above, 10 volunteered for this study (6 men with age of 55.2±13.32 years and 4 women with age of 48.25±14.97 years). This part was based on a prospective, nonrandomized physiotherapeutic intervention, including a targeted physical therapy program.
Patients and methods

Study design and patients
The participation was voluntary. All 55 patients of study I were contacted by mail, which had been sent twice. A total of 17 patients were interested in the program, but because of familial and logistical reasons, only 10 patients could complete the study. Informed consent was obtained from all participants. Age, height, weight, disease duration, drug history, radiological stage, and physical activity level were recorded.
The physical examinations were performed by the same physician (N.B.) before and after the targeted therapy program. All patients had recent respiratory function tests and these were repeated. None of the patients had any overt cardiopulmonary diseases.
Biological therapy
All patients with biological therapy (study I and II) had received etanercept or infliximab according to standard of care for at least 3 months prior to the study [11] .
Physical therapy
The physical therapy program included conventional exercise, global posture reeducation, breathing exercises, manual mobilization of the chest, stretching of the shortened muscles (back, lumbar spine, around hip and shoulder), and functional exercises with joint prevention strategies. 
Manual mobilization of the chest-
Clinical assessments
For the assessment of functional ability and disease activity, the BASFI and BASDAI [17] were recorded. In study II the tests have been completed before and after the 12-week physical therapy program. __Participants were assessed in a clinic-based setting by a trained observer (N.B.). Chest expansion, modified Schober Index, lateral flexion, occiput-to-wall distance, and fingertip-tofloor distance were measured. Each movement had been practiced once before the range of motion was recorded. All baseline and repeat appointments were arranged for the same time.
Furthermore, tender points were detected.
Respiratory function tests
Respiratory function tests typically show mild restrictive respiratory pattern [1] . Spirometry was performed completed before and after the 12-week physical therapy program. Forced vital capacity (FVC), forced expiratory volume during the first second (FEV1), peak expiratory flow (PEF), and maximum voluntary ventilation (MVV) were assessed and recorded. The values were expressed as a percentage of the predicted normal values according to the European Respiratory Society criteria [17] .
Statistical analysis
Differences were evaluated by using paired t-test or Wilcoxon signed rank test, depending on the normality of data distribution. The significance level was set at value of p<0.05. 
Results
Study I: retrospective analysis of patients with or without biological therapy
Study II: prospective analysis of targeted physiotherapy
In the 10 volunteer AS patients with biological therapy (Tab. 2), assessment of disease activity, and pain intensity significantly improved after the 12-week targeted physiotherapeutic program (p=0.002 and p<0.001, respectively; Fig. 2a, b) . __In all cases, improvement in functional parameters and disease activity was observed after the targeted physical therapy program. Both BASFI and BASDAI increased after treatment (p=0.004 and p<0.001, respectively; Fig. 2c, d) . When analyzing the individual changes, almost the same ratio was found when evaluating the "before treatment" versus "after treatment" differences. __Mobility evaluations also revealed significant improvement. Significantly increased finger-to-floor distance (p=0,008), chest expansion (p<0.001), and modified Schober Index (p=0.031) were observed after versus before treatment. The occiput-to wall distance did not change significantly (Fig. 3) . Chest expansion exerted a two-fold increase in the majority of patients. The lateral flexion increased significantly in both sides (p=0.002 right; p=0.006 left), developing symmetrical movements. Fig. 4 ). There were no obvious individual differences, and the degree of FVC improvement seemed to be independent of the magnitude of chest expansion. Means ± S.D., n=10 __Tenderness of typical tender points of the chest indicated improvement and decreased sensitivity to pressure, mainly over the sternocostal, chondrocostal, manubriosternal junction, and xiphoid process regions. The tenderness of sternocostal and costosternal junctions decreased remarkably, but the sacroiliacal pain did not influence motion. From the characterized tender points, the tenderness of the coracoids process, the superior angle of scapula, the great trochanter, and the ischial tuberosities were marked less after exercise therapy. The tenderness of spinosus processes-which was provoked with palpationdecreased, except for the thoracal region. Pain and stiffness of paravertebral muscles showed improvement with smaller number of markings by the patients (Fig. 5, Fig. 6 ).
Fig. 5
Number of markings for tenderness of the a chest-fibrocartilagous junctions and b regional tender points before and after exercise therapy (study II) 
Discussion
In AS, chest pain often occurs as a consequence of costovertebral and costotransverse joint involvement and might be associated with tenderness over sternocostal and costosternal junctions [19, 20] . Pulmonary function abnormalities are due mainly to the restriction of chest wall movement [21] . Restrictive lung disease occurs in kyphoscoliosis and AS due to decreased functional residual capacity, inspiratory capacity, lung compliance, and airway conductance. Some patients reported an inability to expand the chest upon inspiration [13, 21, 22] . The normal chest expansion is 5 cm or greater; however, it is age-and sex-dependent.
Limited chest expansion-in individual insidious onset of chronic low back pain and without chest disease such as emphysema or scoliosis-should strongly raise the possibility of AS [8] .
__Patients in whom disease activity cannot be adequately controlled by conventional techniques may be treated with biological agents targeting TNF-α, which are now licensed for treatment of patients with severe AS whose symptoms do not respond adequately to conventional therapy. Without treatment the spine increasingly stiffens and the peripherial (mostly large) joints are often destroyed by inflammatory processes. Early diagnosis is of utmost importance because today treatment with novel drugs is feasible with TNF-α inhibitors being particularly effective during the early stages of the disease. __Demonstrated by our patients' parameters, the inhibition of inflammation led to lower pain intensity and disease activity, better physical conditions and functionality. In the case of 55 patients, moderate pain, larger MSI and chest expansion were observed, showing decreased BASFI and BASDAI values [23, 24, 25, 26, 27] . The limitation of this study part is its retrospective character. __Physical therapy applied individually or in groups has general and specific beneficial effects for patients suffering from AS [28, 29, 30] . Several studies reported improvement in the wall-to-occiput distance, finger-to-floor distance, chest expansion, Schober Index, and pulmonary function after a couple of weeks of intensive physiotherapy [1, 14, 31, 32] .
__In study II, which was a prospective but nonrandomized self-controlled study, we investigated functional and physical parameters with respect to the above mentioned structural-functional changes in AS patients currently receiving anti-TNF therapy. Results suggested significant improvements in function and mobility. __Our physical exercise program included elements of conventional and breathing exercises as well as global posture reeducation. The stretching theories also played an important role, adapted for the alterations in the column and the chest. The conventional exercises focus on mobilization of the great joints and on strengthening of the shoulder and hip complex muscles. The aim of the breathing exercises is mobilization of the joints in the spinal column and chest, together with development of appropriate breathing mechanics, while the basics of global posture reeducation are spine elongation and hip complex position according to biomechanical analyses [1, 8, 12, 13, 17] . __We observed improvements in finger-to-floor distance and thoracolumbar lateral flexion, slightly in modified Schober Index, while the occiput-to-wall distance did not change markedly. The finger-to-floor distance depends on the extensibility of hamstring muscles and the thoracolumbar lateral flexion is influenced by the extensibility of spine muscles. The occiput-to-wall distance is defined by curvature and mobility of the spine, tilt of the pelvis, and stiffness around the hip and spine [20, 33] . Normal chest expansion requires normal costovertebral, costosternal, manubriosternal, and sternoclavicular joints. If any of these joints are involved, chest expansion is diminished [7, 10, 19] . Our results also showed associations of pain, numbers of tender points, chest expansion, and thoracolumbar lateral flexion. __Durmuş et al. [34] compared the effects of conventional exercise and global posture reeducation (GPR). There were significant improvements for BASDAI and BASFI scores in all groups, significant improvements in the VAS pain, chest expansion, but the GPR method resulted in greater improvements than the conventional exercise program in specific pulmonary function parameters like forced vital capacity, forced expiratory volume in 1 s, and peak expiratory flow parameters. __Previously, the pulmonary function tests of our patients had shown that the typical pattern was restrictive, characterized by low chest expansion and lateral flexion. The restrictive pattern characterized by low FVC is frequently associated with a decreased thoracic expansion [7, 10] . After 12 weeks of targeted physical therapy, respiratory function improved slightly, but not significantly-probably because this program did not contain direct cardiopulmonary exercises. Physical therapy included manual mobilization and breathing exercise, and so these techniques could not ameliorate breathing muscle endurance. The muscles' endurance and response to differenct exercises decrease in AS, which correlated significantly with age, disease duration, chest expansion, modified Shober Index, and vital capacity [35, 36, 37] . __Karapolat et al. [38] found that swimming, walking, and conventional exercise (CE) had beneficial effects on quality of life and pulmonary function. Aerobic exercises such as swimming and walking in addition to CE significantly increased functional capacities of patients. However, no significant differences were detected in the exercise groups with regard to BASDAI and BASFI. __Koseoglu et al. [22] also reported that the exercise training improves some of the spinal and respiratory limitation in AS; however, exercise training, as part of pulmonary rehabilitation, was not sufficient evidence for effectiveness. Comparing with the values recorded at the beginning of the study, they observed slight increases in FVC, FEV1, and MVM. Our results correspond nicely with these observations; however, they also found a significant correlation between FVC, chest expansion, and lumbar flexion. __Ortancil et al. [39] applied a 6-week home-based program, using breathing and upper extremity exercises. In their study, chest expansion, pulmonary function, and BASFI scores significantly improved. In our study, significant improvement of BASFI and BASDAI scores were also found. Sahin et al. [21] suggested a significant negative correlation between functionality and pulmonary muscle strength, but they did not find a significant relation between BASFI and chest expansion.
__Enthesitis is inflammation at the insertion point of ligaments, tendons, joint capsule, or fascia to bone, and a well-known characteristic of AS. Entheseal pain may be mild, moderate, severe, or disabling and, there is a correlation with disease activity, tenderness, and number of tender points [40, 41] . __Back pain and stiffness were dominant in these 75 AS patients. Lower back pain is dependent on inflammatory activity of sacroiliac joints; in particular ankylosis correlates with limited range of motion (ROM), paravertebral stiffness, and the inflammation at the intervertebral, costovertebral, costotransversal joints and fibrocartilagous junctions, which increase pain. __As the result of targeted exercise therapy (in study II), the tenderness of cervical and thoracic spinosus processes decreased, but was stagnant in the thoracic region, whereas motion did not influence the inflammatory process and ragiological conditions [42] . The degree of pain and tenderness correlate with patient assessment of disease activity. The paravertebral region was activated by exercises; therefore, muscles pain and stiffness decreased. Exercise with stretching resulted in favorable structural transformation in muscles (the number of sarcomers increased) and pain decreased [43, 44] . The tenderness of fibrocartilagous junctions showed the greatest improvement. __Beside targeted physiotherapy which includes adapted exercise therapy, biological agents are highly effective in the therapy of AS. Because of the locomotor manifestations of the disease, stimulation of motion is indispensable in therapy, which can improve mobility and function, supplementing the targeted therapy.
__The results of our and previous studies showed that AS patients receiving biological therapy and additional physiotherapy may show remarkable improvement. We suggest that physical therapy has an important and additive role in the complex therapy of AS. For this purpose, a targeted exercise program may contribute to joint protection strategies and pharmacological treatment.
__The ratio of the volunteers (17 of 55 patients, 30.9%; those who completed the program 10 of 55 patients, 18.18%) was very low in our study. This may indicate low motivation of patients for physical activity and exercises in addition to logistic reasons. According to these preliminary results, we are encouraged to continue the studies with this physical exercise combination and increasing the case number for new studies.
Conclusion
Physical therapy may be of important additive value in AS patients being treated with biologicals. Our exercise program improved functional parameters as well as spine and chest mobility, thus, enhancing the positive effects of biological therapy. __Key messages are -complex physiotherapy, in addition to biologics, may improve ankylosing spondylitis, -a targeted physiotherapy program improved pain intensity, and -physiotherapy improved chest mobility and respiratory function.
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